• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Peripheral Vascular Devices Market to 2018 - Increasing Demand for Minimally Invasive Endovascular Procedures Presents Growth Opportunities for Manufacturers - Product Image

Peripheral Vascular Devices Market to 2018 - Increasing Demand for Minimally Invasive Endovascular Procedures Presents Growth Opportunities for Manufacturers

  • Published: October 2012
  • Region: Global
  • 101 Pages
  • GBI Research

FEATURED COMPANIES

  • Abbott Laboratories
  • Boston Scientific
  • C. R. Bard
  • Cordis
  • Covidien
  • Medtronic
  • MORE

GBI Research’s report, “Peripheral Vascular Devices Market to 2018 - Increasing Demand for Minimally Invasive Endovascular Procedures Presents Growth Opportunities for Manufacturers” provides key data, information and analysis for the global peripheral vascular devices market.

It examines the market and competitive landscape and trends for the eight market segments: stent grafts, peripheral vascular stents, Percutaneous Transluminal Angioplasty (PTA) balloons, peripheral embolic protection devices, Inferior Vena Cava Filters (IVCFs), synthetic surgical grafts, peripheral guidewires and PTA peripheral Drug-Eluting Balloons (DEBs). It provides comprehensive information on the key trends affecting these segments and analyzes the market dynamics.

The report also looks at the pipeline products in each segment and gives details regarding important M&A activity. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

- Key market geographies of the US, Canada, the UK, Germany, France, Italy, Spain, Japan, READ MORE >

1.1 List of Tables
1.2 List of Figures

2 Introduction

3 Global Peripheral Vascular Devices Market - Market Characterization
3.1 Peripheral Vascular Devices Market, Revenue ($m), 2004-2011
3.2 Peripheral Vascular Devices Market, Revenue ($m), 2011-2018
3.3 Peripheral Vascular Devices Market, Key Company Shares (%), 2011
3.4 Peripheral Vascular Devices Market, Key Trends
3.4.1 High Risk of Deep Vein Thrombosis Associated with Permanent Filters is Promoting the Use of Retrievable Inferior Vena Cava Filters
3.4.2 Preference of Minimally Invasive Endovascular Procedures to Treat Peripheral Vascular Disease is a Global Trend
3.5 Peripheral Vascular Devices: Market Dynamics
3.5.1 Market Drivers
3.5.2 Market Restraints

4 Global Peripheral Vascular Devices Market - Segment Analysis and Forecasts
4.1 Stent Grafts Market, Global, Revenue ($m), 2004-2011
4.2 Stent Grafts Market, Global, Revenue ($m), 2011-2018
4.3 Peripheral Vascular Stents Market, Global, Revenue ($m), 2004-2011
4.4 Peripheral Vascular Stents Market, Global, Revenue ($m), 2011-2018
4.5 PTA Balloons Market, Global, Revenue ($m), 2004-2011
4.6 PTA Balloons Market, Global, Revenue ($m), 2011-2018
4.7 Peripheral Embolic Protection Devices Market, Global, Revenue ($m), 2004-2011
4.8 Peripheral Embolic Protection Devices Market, Global, Revenue ($m), 2011-2018
4.9 Inferior Vena Cava Filters Market, Global, Revenue ($m), 2004-2011
4.10 Inferior Vena Cava Filters Market, Global, Revenue ($m), 2011-2018
4.11 Synthetic Surgical Grafts Market, Global, Revenue ($m), 2004-2011
4.12 Synthetic Surgical Grafts Market, Global, Revenue ($m), 2011-2018
4.13 Peripheral Guidewires Market, Global, Revenue ($m), 2004-2011
4.14 Peripheral Guidewires Market, Global, Revenue ($m), 2011-2018
4.15 PTA Peripheral Drug-eluting Balloons Market, Global, Revenue ($m), 2004-2011
4.16 PTA Peripheral Drug-eluting Balloons Market, Global, Revenue ($m), 2011-2018

5 Global Peripheral Vascular Devices Market - Country Analysis and Forecasts
5.1 Peripheral Vascular Devices Market: Cross-country Analysis
5.2 Historic and Forecast Revenue, by Country
5.2.1 Peripheral Vascular Devices Market, the US, Revenue ($m), 2004-2011
5.2.2 Peripheral Vascular Devices Market, the US, Revenue ($m), 2011-2018
5.2.3 Peripheral Vascular Devices Market, Canada, Revenue ($m), 2004-2011
5.2.4 Peripheral Vascular Devices Market, Canada, Revenue ($m), 2011-2018
5.2.5 Peripheral Vascular Devices Market, Germany, Revenue ($m), 2004-2011
5.2.6 Peripheral Vascular Devices Market, Germany, Revenue ($m), 2011-2018
5.2.7 Peripheral Vascular Devices Market, the UK, Revenue ($m), 2004-2011
5.2.8 Peripheral Vascular Devices Market, the UK, Revenue ($m), 2011-2018
5.2.9 Peripheral Vascular Devices Market, France, Revenue ($m), 2004-2011
5.2.10 Peripheral Vascular Devices Market, France, Revenue ($m), 2011-2018
5.2.11 Peripheral Vascular Devices Market, Italy, Revenue ($m), 2004-2011
5.2.12 Peripheral Vascular Devices Market, Italy, Revenue ($m), 2011-2018
5.2.13 Peripheral Vascular Devices Market, Spain, Revenue ($m), 2004-2011
5.2.14 Peripheral Vascular Devices Market, Spain, Revenue ($m), 2011-2018
5.2.15 Peripheral Vascular Devices Market, Brazil, Revenue ($m), 2004-2011
5.2.16 Peripheral Vascular Devices Market, Brazil, Revenue ($m), 2011-2018
5.2.17 Peripheral Vascular Devices Market, Japan, Revenue ($m), 2004-2011
5.2.18 Peripheral Vascular Devices Market, Japan, Revenue ($m), 2011-2018
5.2.19 Peripheral Vascular Devices Market, China, Revenue ($m), 2004-2011
5.2.20 Peripheral Vascular Devices Market, China, Revenue ($m), 2011-2018
5.2.21 Peripheral Vascular Devices Market, India, Revenue ($m), 2004-2011
5.2.22 Peripheral Vascular Devices Market, India, Revenue ($m), 2011-2018
5.2.23 Peripheral Vascular Devices Market, Australia, Revenue ($m), 2004-2011
5.2.24 Peripheral Vascular Devices Market, Australia, Revenue ($m), 2011-2018

6 Global Peripheral Vascular Devices Market - Profiles of Key Market Participants
6.1 Cordis
6.1.1 Marketed Products
6.2 Boston Scientific
6.2.1 Marketed Products
6.3 Abbott Laboratories
6.3.1 Marketed Products
6.4 Medtronic
6.4.1 Marketed Products
6.5 C. R. Bard
6.5.1 Marketed Products
6.6 Covidien
6.6.1 Marketed Products
6.7 Terumo
6.7.1 Marketed Products

7 Global Peripheral Vascular Devices Market - Product Pipeline Analysis
7.1 Stent Grafts Market: Product Pipeline
7.1.1 Stent Grafts Market: List of Pipeline Products
7.1.2 Stent Grafts Market: Profiles of Key Pipeline Products
7.2 Peripheral Vascular Stents Market: Product Pipeline
7.2.1 Peripheral Vascular Stents Market: List of Pipeline Products
7.2.2 Peripheral Vascular Stents Market: Profiles of Key Pipeline Products
7.3 PTA Balloons Market: Product Pipeline
7.3.1 PTA Balloons Market: List of Pipeline Products
7.3.2 PTA Balloons Market: Profiles of Key Pipeline Products
7.4 Peripheral Embolic Protection Devices Market: Product Pipeline
7.4.1 Peripheral Embolic Protection Devices Market: List of Pipeline Products
7.4.2 Peripheral Embolic Protection Devices Market: Profiles of Key Pipeline Products
7.5 Inferior Vena Cava Filters Market: Product Pipeline
7.5.1 Inferior Vena Cava Filters Market: List of Pipeline Products
7.5.2 Inferior Vena Cava Filters Market: Profiles of Key Pipeline Products
7.6 Synthetic Surgical Grafts Market: Product Pipeline
7.6.1 Synthetic Surgical Grafts Market: List of Pipeline Products
7.6.2 Synthetic Surgical Grafts Market: Profiles of Key Pipeline Products
7.7 Peripheral Guidewires Market: Product Pipeline
7.7.1 Peripheral Guidewires Market: List of Pipeline Products
7.7.2 Peripheral Guidewires Market: Profiles of Key Pipeline Products
7.8 PTA Peripheral Drug-eluting Balloons Market: Product Pipeline
7.8.1 PTA Peripheral Drug-eluting Balloons Market: List of Pipeline Products
7.8.2 PTA Peripheral Drug-eluting Balloons Market: Profiles of Key Pipeline Products

8 Global Peripheral Vascular Devices Market - Consolidation Landscape
8.1 Deals by Count
8.2 Key Deals (2008-2011)
8.2.1 C. R. Bard’s Acquisition of Lutonix
8.2.2 Medrad’s Acquisition of Pathway Medical Technologies
8.2.3 Boston Scientific’s Acquisition of S.I. Therapies
8.2.4 Endologix’s Acquisition of Nellix Endovascular
8.2.5 St. Jude Medical’s Acquisition of AGA Medical Holdings for $1.3 Billion
8.2.6 Covidien’s Acquisition of ev3 for $2.6 Billion
8.2.7 Degania Silicone’s Acquisition of Arthesys
8.2.8 C. R. Bard’s Acquisition of FlowCardia For $80.1m
8.2.9 Avinger Merges with Sawtooth Labs
8.2.10 Medtronic’s Acquisition of Invatec and Affiliated Companies
8.2.11 Lake Region Medical’s Acquisition of Brivant Medical
8.2.12 Covidien’s Acquisition of Bacchus Vascular
8.2.13 Medical Ventures’ Acquisition of B-Balloon

9 Appendix
9.1 Definitions
9.1.1 Peripheral Vascular Devices
9.2 Acronyms
9.3 Sources
9.4 Research Methodology
9.4.1 Secondary Research
9.4.2 Primary Research
9.4.3 Models
9.4.4 Forecasts
9.4.5 Expert Panels
9.5 Contact Us
9.6 Disclaimer

1.1 List of Tables

Table 1: Peripheral Vascular Devices Market, Global, Revenue ($m), 2004-2011
Table 2: Peripheral Vascular Devices Market, Global, Revenue ($m), 2011-2018
Table 3: Peripheral Vascular Devices Market, Global, Key Company Revenue ($m), 2011
Table 4: Peripheral Vascular Devices Market, Germany, Number of Procedures (‘000), 2005-2008
Table 5: Stent Grafts Market, Global, Revenue ($m), 2004-2011
Table 6: Stent Grafts Market, Global, Revenue ($m), 2011-2018
Table 7: Peripheral Vascular Stents Market, Global, Revenue ($m), 2004-2011
Table 8: Peripheral Vascular Stents Market, Global, Revenue ($m), 2011-2018
Table 9: PTA Balloons Market, Global, Revenue ($m), 2004-2011
Table 10: PTA Balloons Market, Global, Revenue ($m), 2011-2018
Table 11: Peripheral Embolic Protection Devices Market, Global, Revenue ($m), 2004-2011
Table 12: Peripheral Embolic Protection Devices Market, Global, Revenue ($m), 2011-2018
Table 13: Inferior Vena Cava Filters Market, Global, Revenue ($m), 2004-2011
Table 14: Inferior Vena Cava Filters Market, Global, Revenue ($m), 2011-2018
Table 15: Synthetic Surgical Grafts Market, Global, Revenue ($m), 2004-2011
Table 16: Synthetic Surgical Grafts Market, Global, Revenue ($m), 2011-2018
Table 17: Peripheral Guidewires Market, Global, Revenue ($m), 2004-2011
Table 18: Peripheral Guidewires Market, Global, Revenue ($m), 2011-2018
Table 19: PTA Peripheral Drug-eluting Balloons Market, Global, Revenue ($m), 2004-2011
Table 20: PTA Peripheral Drug-eluting Balloons Market, Global, Revenue ($m), 2011-2018
Table 21: Peripheral Vascular Devices Market, Global, Cross-country Analysis, CAGR (%), 2004-2018
Table 22: Peripheral Vascular Devices Market, the US, Revenue ($m), 2004-2011
Table 23: Peripheral Vascular Devices Market, the US, Revenue ($m), 2011-2018
Table 24: Peripheral Vascular Devices Market, Canada, Revenue ($m), 2004-2011
Table 25: Peripheral Vascular Devices Market, Canada, Revenue ($m), 2011-2018
Table 26: Peripheral Vascular Devices Market, Germany, Revenue ($m), 2004-2011
Table 27: Peripheral Vascular Devices Market, Germany, Revenue ($m), 2011-2018
Table 28: Peripheral Vascular Devices Market, the UK, Revenue ($m), 2004-2011
Table 29: Peripheral Vascular Devices Market, the UK, Revenue ($m), 2011-2018
Table 30: Peripheral Vascular Devices Market, France, Revenue ($m), 2004-2011
Table 31: Peripheral Vascular Devices Market, France, Revenue ($m), 2011-2018
Table 32: Peripheral Vascular Devices Market, Italy, Revenue ($m), 2004-2011
Table 33: Peripheral Vascular Devices Market, Italy, Revenue ($m), 2011-2018
Table 34: Peripheral Vascular Devices Market, Spain, Revenue ($m), 2004-2011
Table 35: Peripheral Vascular Devices Market, Spain, Revenue ($m), 2011-2018
Table 36: Peripheral Vascular Devices Market, Brazil, Revenue ($m), 2004-2011
Table 37: Peripheral Vascular Devices Market, Brazil, Revenue ($m), 2011-2018
Table 38: Peripheral Vascular Devices Market, Japan, Revenue ($m), 2004-2011
Table 39: Peripheral Vascular Devices Market, Japan, Revenue ($m), 2011-2018
Table 40: Peripheral Vascular Devices Market, China, Revenue ($m), 2004-2011
Table 41: Peripheral Vascular Devices Market, China, Revenue ($m), 2011-2018
Table 42: Peripheral Vascular Devices Market, India, Revenue ($m), 2004-2011
Table 43: Peripheral Vascular Devices Market, India, Revenue ($m), 2011-2018
Table 44: Peripheral Vascular Devices Market, Australia, Revenue ($m), 2004-2011
Table 45: Peripheral Vascular Devices Market, Australia, Revenue ($m), 2011-2018
Table 46: Peripheral Vascular Devices Market, Global, Product Pipeline Analysis, 2012
Table 47: Stent Grafts Market, Pipeline Product Summary, 2012, Table 1
Table 48: Stent Grafts Market, Pipeline Product Summary, 2012, Table 2
Table 49: Fluency Plus Endovascular Stent Graft, Product Status, 2012
Table 50: Amplatzer TAA Vascular Graft, Product Status, 2012
Table 51: Amplatzer AAA Vascular Graft, Product Status, 2012
Table 52: Peripheral Vascular Stents Market, Global, Pipeline Product Summary, 2012 Table 1
Table 53: Peripheral Vascular Stents Market, Global, Pipeline Product Summary, 2012, Table 2
Table 54: Absolute Pro LL Peripheral Self-Expanding Stent System, the US, Product Status, 2012
Table 55: Complete SE SFA, the US, Product Status, 2012
Table 56: Astron Peripheral Vascular Stent, the US, Product Status, 2012
Table 57: PTA Balloons Market, Global, Pipeline Product Summary, 2012
Table 58: Joker 014, the US, Product Status, 2012
Table 59: Peripheral Embolic Protection Devices Market, Global, Pipeline Product Summary, 2012
Table 60: Montage System, the US, Product Status, 2012
Table 61: Inferior Vena Cava Filters Market, Global, Pipeline Product Summary, 2012
Table 62: Bard Denali Retrievable Inferior Vena Cava Filter System, the US, Product Status, 2012
Table 63: Synthetic Surgical Grafts Market, Global, Pipeline Product Summary, 2012
Table 64: VasoGraft, the US, Product Status, 2012
Table 65: Ariste Anti-Proliferative Vascular Graft, the US, Product Status, 2012
Table 66: MultiGeneGraft, the US, Product Status, 2012
Table 67: Peripheral Guidewires Market, Global, Pipeline Product Summary, 2012
Table 68: Next Generation Fathom, Oncology, the US, Product Status, 2012
Table 69: Endovascular Guidewire, Global, Product Status, 2012
Table 70: PTA Peripheral Drug-Eluting Balloons Market, Global, Pipeline Product Summary, 2012
Table 71: Boston Drug-Eluting Balloon, Europe, Product Status, 2012
Table 72: In.Pact Admiral Drug-Eluting Balloon, the US, Product Status, 2012
Table 73: Lutonix, the US, Product Status, 2012
Table 74: In.Pact Pacific Balloon Catheter, the US, Product Status, 2012
Table 75: Peripheral Vascular Devices Market, M&A, Global, 2008-2011

1.2 List of Figures

Figure 1: Peripheral Vascular Devices Market, Global, Revenue ($m), 2004-2011
Figure 2: Peripheral Vascular Devices Market, Global, Revenue ($m), 2011-2018
Figure 3: Peripheral Vascular Devices Market, Global, Key Company Shares (%), 2011
Figure 4: Usage Trends for Inferior Vena Cava Filters, Global, Volume (Absolute Units), 2004-2011
Figure 5: Peripheral Vascular Devices Market, Germany, Number of Procedures (‘000), 2005-2008
Figure 6: Stent Grafts Market, Global, Volume (‘000), 2004-2011
Figure 7: Increase in the Percentage of Elderly People in the Population, Global (%), 2010-2050
Figure 8: Stent Grafts Market, Global, Revenue ($m), 2004-2011
Figure 9: Stent Grafts Market, Global, Revenue ($m), 2011-2018
Figure 10: Peripheral Vascular Stents Market, Global, Revenue ($m), 2004-2011
Figure 11: Peripheral Vascular Stents Market, Global, Revenue ($m), 2011-2018
Figure 12: PTA Balloons Market, Global, Revenue ($m), 2004-2011
Figure 13: PTA Balloons Market, Global, Revenue ($m), 2011-2018
Figure 14: Peripheral Embolic Protection Devices Market, Global, Revenue ($m), 2004-2011
Figure 15: Peripheral Embolic Protection Devices Market, Global, Revenue ($m), 2011-2018
Figure 16: Inferior Vena Cava Filters Market, Global, Revenue ($m), 2004-2011
Figure 17: Inferior Vena Cava Filters Market, Global, Revenue ($m), 2011-2018
Figure 18: Synthetic Surgical Grafts Market, Global, Revenue ($m), 2004-2011
Figure 19: Synthetic Surgical Grafts Market, Global, Revenue ($m), 2011-2018
Figure 20: Peripheral Guidewires Market, Global, Revenue ($m), 2004-2011
Figure 21: Peripheral Guidewires Market, Global, Revenue ($m), 2011-2018
Figure 22: PTA Peripheral Drug-eluting Balloons Market, Global, Revenue ($m), 2004-2011
Figure 23: PTA Peripheral Drug-eluting Balloons Market, Global, Revenue ($m), 2011-2018
Figure 24: Peripheral Vascular Devices Market, Global, Cross-country Analysis, CAGR (%), 2004-2018
Figure 25: Peripheral Vascular Devices Market, the US, Revenue ($m), 2004-2011
Figure 26: Peripheral Vascular Devices Market, the US, Revenue ($m), 2011-2018
Figure 27: Peripheral Vascular Devices Market, Canada, Revenue ($m), 2004-2011
Figure 28: Peripheral Vascular Devices Market, Canada, Revenue ($m), 2011-2018
Figure 29: Peripheral Vascular Devices Market, Germany, Revenue ($m), 2004-2011
Figure 30: Peripheral Vascular Devices Market, Germany, Revenue ($m), 2011-2018
Figure 31: Peripheral Vascular Devices Market, the UK, Revenue ($m), 2004-2011
Figure 32: Peripheral Vascular Devices Market, the UK, Revenue ($m), 2011-2018
Figure 33: Peripheral Vascular Devices Market, France, Revenue ($m), 2004-2011
Figure 34: Peripheral Vascular Devices Market, France, Revenue ($m), 2011-2018
Figure 35: Peripheral Vascular Devices Market, Italy, Revenue ($m), 2004-2011
Figure 36: Peripheral Vascular Devices Market, Italy, Revenue ($m), 2011-2018
Figure 37: Peripheral Vascular Devices Market, Spain, Revenue ($m), 2004-2011
Figure 38: Peripheral Vascular Devices Market, Spain, Revenue ($m), 2011-2018
Figure 39: Peripheral Vascular Devices Market, Brazil, Revenue ($m), 2004-2011
Figure 40: Peripheral Vascular Devices Market, Brazil, Revenue ($m), 2011-2018
Figure 41: Peripheral Vascular Devices Market, Japan, Revenue ($m), 2004-2011
Figure 42: Peripheral Vascular Devices Market, Japan, Revenue ($m), 2011-2018
Figure 43: Peripheral Vascular Devices Market, China, Revenue ($m), 2004-2011
Figure 44: Peripheral Vascular Devices Market, China, Revenue ($m), 2011-2018
Figure 45: Peripheral Vascular Devices Market, India, Revenue ($m), 2004-2011
Figure 46: Peripheral Vascular Devices Market, India, Revenue ($m), 2011-2018
Figure 47: Peripheral Vascular Devices Market, Australia, Revenue ($m), 2004-2011
Figure 48: Peripheral Vascular Devices Market, Australia, Revenue ($m), 2011-2018
Figure 49: Peripheral Vascular Devices Market, Global, Product Pipeline Analysis (%), 2012
Figure 50: Peripheral Vascular Devices Market, M&A, Number of Deals, Global, 2008-2011

Drug-Eluting Balloons Bounce into Global Market

It looks as though drug-eluting balloons already widely used in Europe are set to burst into the global market, as heart conditions become a more common problem, states a new report by healthcare experts GBI Research.

The new report* looks at peripheral Vascular Disease (PVD), which involves the buildup of plaque, and the subsequent narrowing or blockages in arteries, and insufficient blood flow. The growth of the peripheral vascular devices market is being driven by rising incidence rates of PVD, due to conditions such as diabetes, end-stage renal disease and obesity becoming more widespread.

PVD can be treated surgically or via minimally invasive catheter-based techniques. Minimally invasive procedures such as Percutaneous Transluminal Angioplasty (PTA) and Endovascular aneurysm repair (EVAR) to treat abdominal aortic aneurysms (AAAs) and thoracic aortic aneurysms (TAAs) have become widely adopted, due to improved patient comfort, faster recovery and lower morbidity rates. A broad trend is seeing many patients opt for less invasive procedures over traditional open surgery, driving demand for devices used in these procedures, such as Percutaneous Transluminal Angioplasty (PTA) peripheral Drug-Eluting Balloons (DEBs), peripheral vascular stents, stent grafts and PTA balloons.

The high risk of stent thrombosis means that patients who undergo vascular surgery are often prescribed anti-platelet therapy to prevent clot formation. However, this is unsuitable for elderly patients, pregnant women and individuals at high risk of bleeding. Luckily, DEBs require a shorter regimen of antiplatelet therapy than other treatment options, requiring only three months of therapy, rather than the standard 12 months required for Drug-Eluting Stents (DESs), due to the lower associated risk of thrombosis. DEBs are also able to overcome the various issues associated with stents, such as high risk of restenosis, incomplete drug delivery and limited area coverage for drug delivery, which has increased the demand for DEBs around the world.

While DEBs are accepted by most physicians in Europe, they are yet to be approved in the US, Canada and Japan. These countries offer strong opportunities for market growth if companies can successfully expand here.

* Peripheral Vascular Devices Market to 2018 - Increasing Demand for Minimally Invasive Endovascular Procedures Presents Growth Opportunities for Manufacturers

This report examines the market and competitive landscape and trends for the eight market segments: stent grafts, peripheral vascular stents, Percutaneous Transluminal Angioplasty (PTA) balloons, peripheral embolic protection devices, Inferior Vena Cava Filters (IVCFs), synthetic surgical grafts, peripheral guidewires and PTA peripheral Drug-Eluting Balloons (DEBs). It provides comprehensive information on the key trends affecting these segments and analyzes the market dynamics. The report also looks at the pipeline products in each segment and gives details regarding important M&A activity.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

- Cordis
- Boston Scientific
- Abbott Laboratories
- Medtronic
- C. R. Bard
- Covidien
- Terumo

Question Does the report contain detailed information on procedure volumes per country for each of the product segments?
Answer Unfortunately procedure volumes are only given for Germany.
Question Does the report contain information on sales prices for each product segment by country?
Answer Sales price for each product segment per country isn't given unfortunately.

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos